SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: M. Ramle who wrote (3787)10/21/1999 2:42:00 PM
From: Biomaven  Read Replies (1) of 10280
 
Mazen,

I agree that an acquisition doesn't make sense at this point, given how much they already have on their plate and their comparatively depressed stock price. The market's reaction to MLNM's acquisition of LKST would also make anyone think twice.

However, it is always smart to keep one's eyes wide open - there have been some bargains in the depths of the biotech 3rd tier, and it may always be possible to snap up something real cheap.

As I mentioned once before, CELG would be a partial fit because of its Ritalin ICE, but the rest of the company isn't a great fit. It's also no longer quite as cheap as it was when I first mentioned it.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News